arrow
J

Jean-Marie Michot

Gustave Roussy
H指数:58
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and external validation of a prognostic score associated with poor outcomes in patients receiving immune checkpoint blockade-containing therapies enrolled in early-phase clinical trials

基于早期临床试验中接受免疫检查点阻断治疗患者的预后评分的开发与外部验证:与不良结局相关的评分

2026-07-010
PRE
Acute kidney injury in patients included in early-phase oncology clinical trials, results of the AKITEP study

早期肿瘤学临床试验纳入患者中的急性肾损伤,AKITEP研究的结果

2026-05-260
PRE
Multicenter Analysis of General presentations and Imaging features in Cerebral MUCORmycosis (MAGICMUCOR): toward different entities
2025-12-230
PRE
Early Positron Emission Tomography Response-Adapted Treatment in Low-Risk Diffuse Large B-Cell lymphoma: an open label, multicenter, randomised, non-inferiority phase 3 trial.

早期正电子发射断层扫描反应适应性治疗在低风险弥漫性大B细胞淋巴瘤中的应用:一项开放标签、多中心、随机、非劣效性III期临床试验。

2025-11-170
PRE
Notch pathway inhibition with crenigacestat (LY3039478) in a phase I first-in-human clinical trial for patients with relapsed or refractory non-Hodgkin lymphoma and B-cell chronic lymphocytic leukemia

使用crenigacestat(LY3039478)抑制Notch通路在复发或难治性非霍奇金淋巴瘤和B细胞慢性淋巴细胞白血病患者中的I期首次人体临床试验

2025-07-310
OA
Age Does not Affect the Efficacy of Antibody Drug Conjugates, But is Associated with High-Grade Adverse Events in Patients with Cancer Enrolled in Early Phase Clinical Trials

年龄不影响抗体药物偶联物的疗效,但与在早期临床试验中入组的癌症患者发生高等级不良事件相关。

2025-05-160
PRE
Infectious Complications in Patients Treated With T-cell Engagers as Cancer Immunotherapies, a Descriptive Study From the REISAMIC Registry

T细胞接合剂作为癌症免疫疗法治疗患者的感染并发症:一项来自REISAMIC登记研究的描述性研究

2025-04-010
PRE
Efficacy of anti-PD1 therapy in extranodal NK/T cell lymphoma: A matched cohort analysis from the LYSA

抗PD1疗法在结外NK/T细胞淋巴瘤中的疗效:一项来自LYSA的匹配队列分析

2025-01-200
OA
DETECTION OF CIRCULATING TUMOR DNA (CTDNA) IN CEREBROSPINAL FLUID (CSF) IN PATIENTS WITH GLIOBLASTOMA TREATED IN PHASE I CLINICAL TRIAL
2024-11-110
PRE
Detection of circulating tumor DNA (ctDNA) in cerebrospinal fluid (CSF) in patients with glioblastoma treated in phase I clinical trial

在胶质母细胞瘤患者中,于I期临床试验期间治疗的患者其脑脊液(CSF)中循环肿瘤DNA(ctDNA)的检测

2024-09-010
PRE
Prospective validation of the T cell engager (TCE) score in patients treated with bispecific CD3 TCE antibodies in phase I clinical trials

T细胞接合剂(TCE)评分在I期临床试验中使用双特异性CD3 TCE抗体治疗患者的前瞻性验证

2024-09-010
PRE
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review

T细胞接合器作为抗癌免疫疗法引起的反应和不良事件,全面综述

2024-07-011
PRE
Toxicity of immunotherapy combinations with chemotherapy across tumor indications: Current knowledge and practical recommendations

跨肿瘤适应症的免疫治疗联合化疗的毒性: 当前知识和实用建议

2024-06-019
OAAI
Comprehensive Genetic Profiling Reveals Frequent Alterations of Driver Genes on the X Chromosome in Extranodal NK/T-cell Lymphoma
2024-04-242
PRE